PRMT7 and intrahepatic cholangiocarcinoma: To further reconfirm our ICC results, we performed nuclear and cytosolic protein fractionation and monitored the cellular distribution of TFEB in Caco-2 WT and PRMT7 KO cells treated with SLO by Western blotting.